What is Elicio Therapeutics, Inc. Common Stock's Market Cap?

Elicio Therapeutics, Inc. Common Stock's Market Cap is $60.2M, based on as-reported figures from SEC (XBRL) filings.

What is Elicio Therapeutics, Inc. Common Stock's Enterprise Value?

Elicio Therapeutics, Inc. Common Stock's Enterprise Value is $46.2M, based on as-reported figures from SEC (XBRL) filings.

What is Elicio Therapeutics, Inc. Common Stock's EV / EBITDA?

Elicio Therapeutics, Inc. Common Stock's EV / EBITDA is n/m, based on as-reported figures from SEC (XBRL) filings.

What is Elicio Therapeutics, Inc. Common Stock's Net Income (TTM)?

Elicio Therapeutics, Inc. Common Stock's Net Income (TTM) is -$37.8M, based on as-reported figures from SEC (XBRL) filings.

What is Elicio Therapeutics, Inc. Common Stock's EBITDA?

Elicio Therapeutics, Inc. Common Stock's EBITDA is -$37.7M, based on as-reported figures from SEC (XBRL) filings.

What is Elicio Therapeutics, Inc. Common Stock's Diluted EPS (TTM)?

Elicio Therapeutics, Inc. Common Stock's Diluted EPS (TTM) is -1.44, based on as-reported figures from SEC (XBRL) filings.

What is Elicio Therapeutics, Inc. Common Stock's Net Debt?

Elicio Therapeutics, Inc. Common Stock's Net Debt is -$13.9M, based on as-reported figures from SEC (XBRL) filings.

Elicio Therapeutics, Inc. Common Stock (ELTX) Financial Statements

Elicio Therapeutics, Inc. Common Stock

SIC 2834 · PHARMACEUTICAL PREPARATIONS

FIGI BBG00444GM11

XNAS · usd

2.29▼ 0.06 (-2.55%)

As of 2026-09-09

Valuation

Market Cap

Enterprise Value

Trailing P/E—

Price / Sales—

EV / Revenue—

EV / EBITDA

Financial Highlights

Revenue (TTM)—

Net Income (TTM)

EBITDA

Diluted EPS (TTM)

EBITDA Margin—

Net Debt

Trading Information

Previous Close2.35

Day's Range2.34 – 2.46

52-Week Range2.34 – 16.00

Volume321.1K

Avg Volume293.1K

Share Statistics

Shares Outstanding

Employees33

ExchangeXNAS

Listed2023-06-02

Share count as of August 11, 2026

ViewDetail

Period

Loading Income Statement…

Key questions about Elicio Therapeutics, Inc. Common Stock (ELTX)

What is Elicio Therapeutics, Inc. Common Stock's Market Cap?: Elicio Therapeutics, Inc. Common Stock's Market Cap is $60.2M, based on as-reported figures from SEC (XBRL) filings.
What is Elicio Therapeutics, Inc. Common Stock's Enterprise Value?: Elicio Therapeutics, Inc. Common Stock's Enterprise Value is $46.2M, based on as-reported figures from SEC (XBRL) filings.
What is Elicio Therapeutics, Inc. Common Stock's EV / EBITDA?: Elicio Therapeutics, Inc. Common Stock's EV / EBITDA is n/m, based on as-reported figures from SEC (XBRL) filings.
What is Elicio Therapeutics, Inc. Common Stock's Net Income (TTM)?: Elicio Therapeutics, Inc. Common Stock's Net Income (TTM) is -$37.8M, based on as-reported figures from SEC (XBRL) filings.
What is Elicio Therapeutics, Inc. Common Stock's EBITDA?: Elicio Therapeutics, Inc. Common Stock's EBITDA is -$37.7M, based on as-reported figures from SEC (XBRL) filings.
What is Elicio Therapeutics, Inc. Common Stock's Diluted EPS (TTM)?: Elicio Therapeutics, Inc. Common Stock's Diluted EPS (TTM) is -1.44, based on as-reported figures from SEC (XBRL) filings.
What is Elicio Therapeutics, Inc. Common Stock's Net Debt?: Elicio Therapeutics, Inc. Common Stock's Net Debt is -$13.9M, based on as-reported figures from SEC (XBRL) filings.